Probi AB

Probi AB (publ) is a Swedish company specializing in the development, production, marketing, and sale of probiotic solutions for clients in the health, pharmaceutical, and food industries. Their research primarily focuses on improving gastrointestinal, digestive, immune, and bone health, as well as iron absorption, along with specific health needs for children, women, and seniors. Probi offers a diverse range of dietary supplements and food and beverage products, available in various forms including capsules, tablets (standard, spherical, and chewable), powders, and liquid formats like fruit drinks, shots, carbonated beverages, and recovery drinks. The company's products are sold in approximately 40 countries globally. They maintain research collaborations, notably with Örebro University for developing needle-free vaccines and with La Trobe University for a clinical trial investigating Probi Osteo's effects on Australian women. Founded in 1991 and headquartered in Lund, Sweden, Probi AB (publ) is a subsidiary of Symrise AG.